Is Netease Ntes Stock Overvalued Now Price At 112.81 Up 0.13 20260402 PPT Putnam reports 213 percent yearoveryear Q1 2026 revenue decline stock edges 025 percent higher IFN Aberdeen management cites robust Indian equity tailwinds while discussing its latest quarterly earnings results RXRX Recursion Pharmaceuticals EPS beats estimates by 20 shares rise 265 on positive momentum Forrester Research FORR posts earnings miss of 1327 expenses outpacing revenue amid turnaround efforts Federal Reserve Chair Nomination Confirmation Status Analysis